Atopic Eczema

27 registered clinical trials studyying Atopic Eczema — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	A Study to Evaluate the Efficacy and Safety of MG-K10 in Participants Who Have Atopic Dermatitis NCT07479615	Shanghai Mabgeek Biotech.Co.Ltd	Phase 3
Not Yet Recruiting	Cutaneous Biomarkers in Atopic Eczema Using a Non-Invasive Micro-Suction Device in Babies NCT07228962	King's College London	—
Not Yet Recruiting	Efficacy of Crisaborole 2% Cream Versus Placebo in Mild to Moderate Atopic Eczema NCT07438509	Jinnah Postgraduate Medical Centre	Phase 4
Recruiting	Safety, Tolerability and PK of ATTO-3712 in Healthy Volunteers and Patients With Atopic Dermatitis NCT07205081	Attovia Therapeutics Inc	Phase 1
Active Not Recruiting	Safety, Tolerability and PK of ATTO-1310 in Healthy Volunteers and Patients With Atopic Dermatitis and Patient NCT06787586	Attovia Therapeutics Inc	Phase 1
Recruiting	A Study to Evaluate the Emollient Performance of Doublebase Once in the Treatment of Atopic Eczema NCT06453512	Dermal Laboratories Ltd	N/A
Active Not Recruiting	A Pilot Study of Efficacy and Safety of SIM05 in Adults With Atopic Eczema NCT06230991	Chinese University of Hong Kong	N/A
Completed	Dupilumab in Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-severe Eczema Trial NCT05590585	Regeneron Pharmaceuticals	Phase 4
Completed	A Study to Evaluate Adex Gel in the Treatment of Atopic Eczema. NCT05454722	Dermal Laboratories Ltd	N/A
Completed	The Effects of Topical Corticosteroid Use on Insulin Sensitivity and Bone Turnover NCT04114097	Jacob Thyssen	Phase 4
Completed	A Community-based Assessment of Skin Care, Allergies, and Eczema NCT03409367	Oregon Health and Science University	N/A
Unknown	Softened Water for Eczema Prevention Pilot Trial NCT03270566	King's College London	N/A
Unknown	A Longitudinal Investigation of Skin Barrier Development From Birth and the Validation of Early Predictors of NCT03143504	Sheffield Teaching Hospitals NHS Foundation Trust	—
Completed	Narrowband Ultraviolet B Versus Narrowband Ultraviolet B Plus Ultraviolet A1 for Atopic Eczema NCT02915146	University of Dundee	N/A
Completed	Role of Anti-IgE in Severe Childhood Eczema NCT02300701	Guy's and St Thomas' NHS Foundation Trust	Phase 4
Completed	Evaluation of an Integrated Care Project NCT01854580	Charite University, Berlin, Germany	—
Completed	Study to Investigate Skin Conditions and Patient Assessment of LAS 41002 in the Treatment of Atopic Eczema NCT01119313	Almirall, S.A.	Phase 2
Completed	Comparison of Video-Based Versus Written Patient Education on Atopic Dermatitis NCT00826592	University of California, Davis	N/A
Completed	Topical Treatment With Fresh Human Milk Versus Emollient on Atopic Eczema Spots in Young Children NCT02381028	Oslo University Hospital	N/A
Completed	Regulatory T Cells (Tregs) in Polymorphic Light Eruption NCT00555178	Medical University of Graz	—
Completed	Montelukast as a Controller of Atopic Syndrome NCT00559546	University of Helsinki	Phase 4
Completed	A Phase 2a Study to Investigate the Effects of Repeated Administration of AeroDerm in Subjects With Atopic Ecz NCT00676884	Aerovance, Inc.	Phase 2
Completed	A Quality of Life and Safety Study With Pimecrolimus Cream, 1% in Children (Age 2-12 Years) With Atopic Dermat NCT00484003	Novartis	Phase 4
Completed	Skin Tolerance Study of Betamethasone Creams in Atopic Eczema and the Preventative Properties of a Moisturiser NCT00576238	ACO Hud Nordic AB	Phase 3
Completed	Double-Blind, Parallel, Randomised Study to Investigate the Effect of Oral Probiotics in Infants With Atopic D NCT00224432	Groningen Research Institute for Asthma and COPD	N/A
Completed	Atopic Dermatitis Biomarker Identification Trial in Omalizumab Usage NCT01179529	Technical University of Munich	Phase 2
Unknown	Effect of Moisturizing Creams on Skin Barrier Function NCT00771121	ACO Hud Nordic AB	Phase 4